Hui Gan | Molecular and Cellular Neuroscience | Research Excellence Award

Dr. Hui Gan | Molecular and Cellular Neuroscience | Research Excellence Award

Dr. Hui Gan | Chongqing Medical University | China

Professor Hui Gan is a distinguished researcher at Chongqing Medical University, serving as a master’s supervisor, associate research fellow, and Assistant to the Dean of the School of Basic Medical Sciences, where she also leads the Department of Pathophysiology in an acting capacity. Her research primarily focuses on neuroinflammation, microglial regulation, and inflammasome-mediated injury following cerebral hemorrhage, with significant contributions to understanding TRIM21-mediated mechanisms and microglial transcriptional pathways such as c-MAF–NLRP3 signaling. She has secured multiple competitive national and regional research grants supporting investigations into inflammasome activation, microcirculatory dysfunction, and post-hemorrhagic inflammatory injury. Professor Gan has received notable recognitions, including awards for early-career excellence and contributions to microcirculation research. She plays an active role in professional societies as a committee member of the Microcirculation Committee of the Chinese Society of Pathophysiology and a young committee member of the Translational Medicine Committee of the Chinese Society of Microcirculation, contributing to academic development in basic and translational medical sciences. Her scholarly output includes 18 documents, with 196 citations across 175 citing documents, reflecting a solid research impact supported by an h-index of 8. Through her scientific leadership and innovative research, she continues to advance understanding of inflammatory mechanisms in neurological injury.

Profile: Scopus

Featured Publication

Gan, H., Gan, H.-Y., Zhang, M., Duan, Y., Palahati, A., He, Q., Tan, J., Li, Y., Zhai, X., & Zhao, J. (2025). Microglial NFAT5 aggravates neuroinflammation via mediating NLRP6 inflammasome in experimental ischemic stroke. Genes and Diseases, 12(6),

Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Wagdy Khalil | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Wagdy Khalil |  National Research Centre | Egypt

Dr. Wagdy Khalil is a Professor of Animal Genetics specializing in Molecular Genetics at the Cell Biology Department, National Research Centre, Egypt. His research focuses on genetic and molecular mechanisms underlying animal reproduction, gene expression, and environmental genotoxicity. He has significantly contributed to the understanding of oocyte maturation, preovulatory hormonal regulation, and molecular responses to toxins, nanoparticles, and natural therapeutic agents. Dr. Khalil’s work integrates molecular biology, biotechnology, and animal genetics to explore the genetic basis of fertility, mutagenicity, and disease resistance. He has published 161 scientific papers in peer-reviewed journals indexed in Scopus, reflecting his consistent research productivity and international collaboration. His studies have advanced knowledge in fields such as reproductive biology, toxicogenomics, molecular diagnostics, and genetic engineering. Dr. Khalil’s impactful research has earned him 2,055 citations from 1,801 documents, demonstrating wide recognition within the scientific community. With an h-index of 27, his work continues to influence emerging research in molecular genetics and biotechnology, bridging fundamental discoveries with applied biomedical and agricultural innovations.

Featured Publications

  • Antiarthritic activities of berberine in a rat model of gouty arthritis. (2025). Scientific Reports.

  • Unravelling the mechanism by which vildagliptin and linagliptin inhibit pyroptosis in lung injury through the NLRP3 inflammatory pathway in type 1 diabetic rats. (2025). Scientific Reports.

  • Comparative study of pyridine and pyrimidine derivatives as promising anti-inflammatory agents: Design, synthesis, and LPS-induced RAW 264.7 macrophages. (2025). Drug Development Research.

  • Expression of growth factors in buffalo ovarian tissue across different follicular developmental stages. (2025). Archives of Gynecology and Obstetrics.

  • Estrus, preovulatory LH surge and oocyte maturation in Goettingen miniature pigs (Sus scrofa domesticus). (2025). Theriogenology.

  • Targeting apoptotic pathways in cancer: Design, synthesis, and molecular docking studies of 1,3,5-trisubstituted-1H-pyrazole derivatives with Bcl-2 inhibition and DNA damage potential. (2025). RSC Advances.

  • Assessment of the gold nanoparticles biosynthesized using Casuarina equisetifolia bark extract against the ethion-induced hepato- and neurotoxicity in rats. (2025). Journal of Genetic Engineering and Biotechnology.

  • In vitro and in vivo antidiabetic evaluation of new coumarin and chromone derivatives: Design, synthesis, and molecular modeling. (2025). Bioorganic Chemistry.

  • Potential therapeutic effects of interleukin-1 receptor type 1 antagonist and the ethyl acetate fraction of Murraya exotica leaves against κ-carrageenan-induced vein thrombosis in rats. (2025). Phytomedicine Plus.

  • The ability of stressor factors of environmental pollution to induce ROS and 8-OHdG mediated apoptosis in fish species of Suez Gulf, Red Sea. (2025). Egyptian Journal of Chemistry.

Lin Xiao | Cellular Neuroscience | Best Researcher Award

Dr. Lin Xiao | Cellular Neuroscience | Best Researcher Award

Dr. Lin Xiao | Institute for Brain Research and Rehabilitation | China

Dr. Lin Xiao is a distinguished Professor of Neuroscience at the Institute for Brain Research and Rehabilitation, South China Normal University, whose pioneering research has significantly advanced understanding of oligodendrocyte biology and myelin plasticity. His work elucidates the mechanisms by which adaptive myelination contributes to motor learning and memory, proposing a novel “biphasic plasticity model” that distinguishes distinct phases of learning and consolidation. Dr. Xiao’s research has been published in leading journals including Nature Neuroscience, Science, Nature Communications, and Advanced Science, collectively garnering over 2,800 citations and an h-index of 28, with approximately 20 peer-reviewed articles. His landmark paper in Nature Neuroscience has become a classic reference with over 500 citations, demonstrating substantial influence in the field. He has led multiple projects funded by the National Natural Science Foundation of China, including completed and ongoing studies, and established major collaborations with institutions such as University College London. His research areas include glial–neuron interactions, mechanisms of remyelination, neurodevelopmental disorders such as autism, and psychiatric disorders including depression. These contributions have been recognized with national awards and have opened promising avenues for therapeutic strategies in demyelinating and cognitive disorders.

Profiles: Google Scholar | Orcid | Research Gate  

Featured Publications

Marques, S., Zeisel, A., Codeluppi, S., Van Bruggen, D., Mendanha Falcão, A., et al. (2016). Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science, 352(6291), 1326–1329.

Xiao, L., Ohayon, D., McKenzie, I. A., Sinclair-Wilson, A., Wright, J. L., Fudge, A. D., et al. (2016). Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning. Nature Neuroscience, 19(9), 1210–1217.

Liu, S., Yu, M., He, Y., Xiao, L., Wang, F., Song, C., Sun, S., Ling, C., & Xu, Z. (2008). Melittin prevents liver cancer cell metastasis through inhibition of the Rac1‐dependent pathway. Hepatology, 47(6), 1964–1973.

Li, C., Xiao, L., Liu, X., Yang, W., Shen, W., Hu, C., Yang, G., & He, C. (2013). A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination. Glia, 61(5), 732–749.

Feng, P. A. N. (2003). Fast mode decision for intra prediction. JVT-G013, March 2003.

Li, Y. X., Ding, S. J., Xiao, L., Guo, W., & Zhan, Q. (2008). Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1α and erythropoietin. Neuroscience Bulletin, 24(2), 89–95.